The HQT sufficiently reduced the accumulation of lipids, such as TG, CHOL, HDL-C, and LDL-C, and inflammation indicators, such as TNF-α, IL-6, and IL-1β levels, indicating its lipid-lowering and anti-inflammatory effects on alleviating NAFLD progression. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.